SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VD's Model Portfolio & Discussion Thread

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Vector1 who wrote (2605)9/24/1997 1:18:00 AM
From: Andrew H   of 9719
 
Hey, dude, pass this by the new analyst V6 and see what he says:

This was from the March 97 10K. There have been more announced since.

>> The Company has announced collaborations with SmithKline Beecham Corporation, Whitehall Robins Healthcare, a division of American Home Products Corporation, The Boots Company plc and McNeil Consumer Products Company, a division of Johnson & Johnson for development of Flash Dose(TM) and EZ Chew(TM)
formulations of OTC products. In addition, the Company has recently
announced development agreements for an OTC product with Bayer Corporation, a prescription product with Astra AB, and a number of veterinary products with IDEXX Laboratories, Inc. The Company is party to an agreement with Kos Pharmaceuticals Inc. for the development of controlled release, once-daily dosage formulations of five major prescription drugs. In the food products market, the Company has entered into agreements with British Sugar, ConAgra,
General Mills, Hershey Foods and Leaf Group B.V.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext